UW Vaccine & Treatment Evaluation Unit

December 28, 2020

Novavax COVID-19 Vaccine Trial

The University of Washington Virology Research Clinic is studying whether an investigational vaccine can prevent COVID-19 in adults. If you are 18 years of age or older and are at increased risk for COVID-19 exposure, you may be eligible for the study. The study will last for about two years and will require 8-10 in-person visits. Procedures will include two vaccinations, physical exams, nasal swabs, and blood draws.

Participants will be compensated $1,250 if they complete the entire trial, plus additional compensation for any unscheduled visits required by the study.

Please contact us at (206) 520-4212 or email us at joinuwcovid19vax@uw.edu for more information.